Blog
Want Better Returns? Don't Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Sterling Infrastructure (STRL) is on the Move, Here's Why the Trend Could be Sustainable
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a
Holley (HLLY) Is Attractively Priced Despite Fast-paced Momentum
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks
ASTS Stock Before Q2 Earnings: A Smart Buy or Risky Investment?
AST SpaceMobile ASTS is scheduled to report second-quarter 2025 earnings on Aug 11, 2025, after market closes. The Zacks Consensus Estimate for revenues and earnings is pegged at $5.15 million and a
Embraer's Q2 Earnings Miss Estimates, Revenues Increase Y/Y
Shares of Embraer S.A. (ERJ) gained 2.1% to reach $58.39 on Aug. 8, following the release of its second-quarter 2025 results.
The company reported a second-quarter 2025 adjusted loss of 2 cents per
Will AEVA's $50M LG Alliance Fast-Track Multi-Sector Growth?
Aeva Technologies AEVA recently announced a $50 million partnership with LG Innotek, a major global manufacturer. The two companies will work together to combine AEVA's special LiDAR technology with
4 Stocks to Bet on as Nasdaq's Northbound Journey Continues
The Nasdaq’s northbound journey continues, with tech stocks fueling the broader market rally over the past few weeks. The Dow, the S&P 500 and the Nasdaq have hit multiple all-time closing highs
Hot EV and AV Stocks That You Can't Afford to Miss
An updated edition of the June 27, 2025 article.
Electric and self-driving cars are reshaping the auto industry. According to the latest report on global EV outlook by International Energy Agency
If You Invested $1000 in Shopify a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors
If You Invested $1000 in Kinross Gold 10 Years Ago, This Is How Much You'd Have Now
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors
If You Invested $1000 in Broadcom Inc. a Decade Ago, This is How Much It'd Be Worth Now
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across
If You Invested $1000 in Agnico Eagle Mines a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
The Zacks Medical - Dental Supplies industry in the Medical sector is reflecting weakness amid rising tariffs by the U.S. government on its trading partners, especially China. The tariffs are
Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract
Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 32 cents for the second quarter of 2025, down 38.5% year over year. The figure fell short of the Zacks Consensus Estimate by
HOOD Jumps 3.1% After its Valuation Crosses Historic $100 Billion Mark
On Friday, Aug. 8, Robinhood Markets, Inc. HOOD achieved a landmark milestone, with its market capitalization surpassing the $100 billion mark for the first time. This watershed moment underscored a
PowerFleet (AIOT) Q1 Earnings Match Estimates
PowerFleet (AIOT) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $0.21 per share a year ago. These figures are adjusted
Perion Network (PERI) Q2 Earnings and Revenues Surpass Estimates
Perion Network (PERI) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.26 per share a year ago. These
Permian Resources Q2 Earnings Decline Y/Y on Increased Expenses
Permian Resources Corporation PR reported second-quarter 2025 adjusted net income per share of 27 cents, in line with the Zacks Consensus Estimate. However, the bottom line declined from the
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.18 per share a year ago. These
International Money Express (IMXI) Tops Q2 Earnings Estimates
International Money Express (IMXI) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.55 per share a year
Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates
Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.27 per share a year ago. These figures
Aaon (AAON) Q2 Earnings and Revenues Miss Estimates
Aaon (AAON) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.62 per share a year ago. These figures are
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Misses Revenue Estimates
Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to a loss of $0.58 per share a year ago
Monday.com (MNDY) Q2 Earnings and Revenues Beat Estimates
Monday.com (MNDY) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.94 per share a year ago. These figures


